July 09, 2012 14:39 ET

Healthcare Leader Physiomed Identifies the Need for HEMOCODE™

HEMOCODE™ Now Available at Select Physiomed Locations

TORONTO, ONTARIO--(Marketwire - July 9, 2012) - From weight gain to IBS to general discomfort, people are accepting the connection between our overall well-being and the food we eat. As a result, complementary healthcare resources such as Canada's HEMOCODE™ Food Intolerance System have been embraced and are increasing in their accessibility.

Physiomed, one of Canada's largest and fastest-growing network of healthcare clinics, has recognized the need to now incorporate diet-based wellness into its collective approach to leading healthcare solutions and is proud to now provide the HEMOCODE™ Food Intolerance Testing System at select locations.

Physiomed clinics focus on the treatment, physical conditioning, and education of Canadians to promote long-term health, and believe that the nutritional wellness driven by HEMOCODE™ is an important tool and possible first step in maintaining and managing specific and overall wellness.

"I have been an advisor to Gemoscan Canada, Inc., the company that owns Hemocode, since 2006 and a Director of the Board since 2010," said Dr. Scott Wilson, DC, Founder and CEO of Physiomed. "Lately and increasingly, I find that the issues faced by our growing patient base would undoubtedly benefit from the kind of comprehensive approach to diet-based wellness that only Hemocode can provide. The time is now right for Hemocode at Physiomed."

With the spotlight currently on health crises such as the obesity epidemic, it's becoming clear that new and more far-reaching healthcare options must be considered alongside traditional western medicine. New research from the University of Miami Miller School of Medicine and Zhengzhou University in China suggests that understanding individual reactions to specific foods is an essential part of maintaining a healthy lifestyle and potentially managing obesity and Irritable Bowel Syndrome.

"There is a definite spike in the number of healthcare practitioners and clinics that offer the nutritional wellness benefits of Hemocode as a mainstay of an overall routine for well-being," said Brian Kalish, CEO Gemoscan, Inc. "We are thrilled that Physiomed is working closely with us to bring Hemocode, Canada's most complete diet and nutritional based wellness system, to its patients."

Under the supervision by Naturopathic Doctors, the HEMOCODE™ Food Intolerance System not only aids in the management of potentially physically-reactive foods, but also provides personalized dietary guidelines that include replacement foods, personalized recipes chosen to compliment acceptable foods and a list of daily recommended vitamins and supplements based on personal reports, to help during each step of the food intolerance and nutritional management process. This makes HEMOCODE™ the most comprehensive approach to the management of food sensitivities available to consumers in the market today. HEMOCODE™ may also be covered by many extended insurance plans if individuals have extended health benefits that include naturopathy.


Physiomed is one of Canada's largest and fastest growing franchisee networks of healthcare clinics. Its founder, Dr. Scott Wilson, DC, began helping Canadians improve their health in 1994 and has since brought together a team of hundreds of highly skilled healthcare professionals from over a dozen disciplines. Physiomed is proud to have helped improve the health and fitness of hundreds of thousands of Canadians.

For more information, please visit: www.physiomed.ca


The HEMOCODE™ Food Intolerance System is a personalized naturopathic nutritional program that promotes dietary well-being. It uses patented technology and services to provide consultation and recommendations to simplify the management of food sensitivities. The HEMOCODE™ Food Intolerance System is one of a growing number of wellness services and products offered by pharmacies as complementary medical choices. Complementary medicine is an adjunct to conventional medical practice, incorporating alternative modalities and therapies with a focus on lifestyle and wellness. A statistically significant base of practitioners and those using HEMOCODE™ report improved dietary wellness and satisfaction.


Gemoscan is an industry leader in food intolerance management and maintains a first- to-market position with Canada wide distribution through select retail partners. Founded in 2003, using its proprietary patented technology; Gemoscan develops, owns and markets comprehensive food sensitivity and dietary management solutions for consumers, including the HEMOCODE™ Food Intolerance System, a personalized naturopathic nutritional program that promotes well-being. Gemoscan is the first and only provider to commercialize a food intolerance management solution directly to consumers in partnership with retailers, and today offers the most comprehensive services available.

Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange (TSX-V) under the symbol GES and is quoted on the Munich, Frankfurt and Stuttgart Stock Exchanges under the symbol 1GE.

Forward-Looking Information

This news release contains certain "forward-looking information". All statements, other than statements of historical fact that address activities, events or developments that Gemoscan believes, expects or anticipates will or may occur in the future. These forward-looking statements reflect the current expectations or beliefs of Gemoscan based on information currently available to Gemoscan. Forward-looking statements are subject to a number of significant risks and uncertainties and other factors that may cause the actual results of Gemoscan to differ materially from those discussed in the forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on Gemoscan. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Gemoscan disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Although Gemoscan believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information